Showing results (1761-1770 of 1,960) with videos related to

Sort By:
Pageof 196
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2012
Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphomaAnas Younes, Ajay K Gopal, Scott E Smith, et al.
Blood Cancer Journal|August 26, 2017
Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphomaS I Tracy, M J Maurer, T E Witzig, et al.
JCO Oncology Practice|May 17, 2022
Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard CareSurbhi Sidana, Cristine Allmer, Melissa C Larson, et al.
American Journal of Hematology|February 18, 2017
Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphomaN Nora Bennani, Betsy R LaPlant, Stephen M Ansell, et al.
American Journal of Hematology|January 2, 2023
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experienceKaran L Chohan, Jonas Paludo, Nishanth Vallumsetla, et al.
Gynecologic Oncology|May 31, 2024
Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and overOmali Pitiyarachchi, Peter J Ansell, Robert L Coleman, et al.
Blood Advances|October 18, 2021
Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomesAlessia Castellino, Yucai Wang, Melissa C Larson, et al.
Blood Advances|July 18, 2022
Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort studyAung M Tun, Arushi Khurana, Raphael Mwangi, et al.
Blood Cancer Journal|November 13, 2023
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort studyAllison M Bock, Jennifer J Gile, Melissa C Larson, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 19, 2021
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional ExperienceN Nora Bennani, Aung M Tun, Kenneth R Carson, et al.
Pageof 196